RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Abhijit Date to Herpes Genitalis

Back to Details
This is a "connection" page, showing publications Abhijit Date has written about Herpes Genitalis.
Abhijit Date
Connection Strength
1.379
Herpes Genitalis
  1. Mallick S, Sharma P, Yadavalli T, Koganti R, Singh SK, Yoshimura K, Kapoor D, Sutar Y, Adams JS, Annaji M, Shukla D, Date AA. Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. Int J Pharm. 2026 Apr 25; 695:126672.
    View in: PubMed
    Score: 0.971
  2. Sutar Y, Singh SK, Dhoble S, Mali J, Adams J, Yadavalli T, Date AA, Shukla D. Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice. ACS Infect Dis. 2024 01 12; 10(1):93-106.
    View in: PubMed
    Score: 0.206
  3. Yadavalli T, Singh SK, Date AA, Shukla D. Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795. Biomed Pharmacother. 2023 Sep; 165:115056.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support